PTEN and prostate carcinoma: PTEN loss is probably the single most reliable genetic alteration associated with prostate cancer progression: inactivation of PTEN by mutation or deletion was identified in ~20% of primary prostate cancers at radical prostectomy and in as may as 50% of castration-resistant prostate cancers [363].